Skip to main content

Table 4 Association between NAC regimens/cycles and serum IgG hypoplasia

From: Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma

 

IgG < 665

NAC regimen, n (%)

 FP

4 (9%)

 DCF

6 (19%)

NAC cycles, n (%)

 1

3 (13%)

 2

7 (13%)